Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet

This study aimed to determine whether modulation of the gut microbiota structure by liraglutide helps improve nonalcoholic fatty liver disease (NAFLD) in rats on a high-fat diet (HFD). Rats were administered an HFD for 12 weeks to induce NAFLD and then administered liraglutide for 4 additional weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ningjing, Tao, Junxian, Gao, Lijun, Bi, Yan, Li, Ping, Wang, Hongdong, Zhu, Dalong, Feng, Wenhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049398/
https://www.ncbi.nlm.nih.gov/pubmed/32149099
http://dx.doi.org/10.1155/2020/2947549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049398/
https://www.ncbi.nlm.nih.gov/pubmed/32149099
http://dx.doi.org/10.1155/2020/2947549

Ejemplares similares